Maria Babak: The progress on vimseltinib for TGCT and TransTACs for drug-resistant cancers

Maria Babak shared a post on LinkedIn by The Babak Lab adding:

“These advancements in cancer research are truly exciting! The progress on vimseltinib for TGCT and TransTACs for drug-resistant cancers is a game-changer, providing hope for patients with limited options. The simple guide on how cancer starts is a must-read for anyone looking to understand the basics and take preventive steps.
Have you ever wondered how targeted therapies work or how your immune system can be harnessed to fight cancer? What new breakthroughs in cancer treatment are you most interested in learning about?
Check it out to stay ahead of the latest in cancer research and empower yourself with knowledge!”

Quoting The Babak Lab’s post below:

“Weekly Digest Groundbreaking Advances in Cancer Treatment and Understanding

This week’s digest brings together the latest strides in cancer therapy, from innovative treatments for drug-resistant tumors to a simple yet comprehensive guide on how cancer starts and grows. Here’s why you should dive in:

1.Breakthrough in Tenosynovial Giant Cell Tumor (TGCT) Treatment
A clinical trial of vimseltinib has shown a 72% response rate for patients where surgery isn’t an option. With long-lasting responses and minimal side effects, this marks a potential game-changer in TGCT treatment.
Why read? Stay ahead on how targeted therapies are reshaping oncology care.

2.TransTACs: Revolutionizing Drug-Resistant Cancer Treatment
Transferrin Receptor Targeting Chimeras (TransTACs) are tackling drug resistance by degrading essential proteins in cancer cells. They can also fine-tune immunotherapies like CAR-T cells, offering 80% degradation efficiency with minimal side effects.
Why read? Discover how TransTACs could lead the next wave of personalized cancer treatment.

3.How Cancer Starts and Grows: A Simple Guide
Understanding cancer’s development is crucial. This guide explains how genetic mutations lead to uncontrolled cell growth and how cancer spreads in the body. It also touches on why early detection and lifestyle changes can lower risk.
Why read? Empower yourself with knowledge to make informed decisions about cancer prevention and treatment.

Stay informed on these major advances in cancer research to better understand the fight against this complex disease!”

Source: Maria Babak/LinkedIn and The Babak Lab/LinkedIn

Dr. Maria (Masha) Babak is the Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong. In November 2020, she joined the City University of Hong Kong as an assistant professor. Dr. Babak received the Graeme Hanson-AsBIC Early Career Award in 2022.

Her research interests are at the intersection of chemistry, biology, and medicine, with a focus on the discovery and preclinical development of anticancer drugs for resistant and aggressive cancers with limited treatment options, such as malignant pleural mesothelioma and brain metastases.